Cipla gains despite its arm receives two inspectional observations from USFDA

[ad_1] Mumbai, February 11 (Udaipur Kiran): Cipla is currently trading at Rs. 1347.65, up by 5.55 points or 0.41% from its previous closing of Rs. 1342.10 on the BSE. The scrip opened at Rs. 1348.20 and has touched a high and low of Rs. 1350.00 and Rs. 1335.00 respectively. So far 29185 shares were traded […]

Wockhardt Shares Surge as USFDA Accepts NDA for Antibiotic Zaynich | Udaipur Kiran

[ad_1] Mumbai, December 2 (Udaipur Kiran): Wockhardt was trading sharply higher at Rs. 1,504.25 on the BSE, up by 33.35 points or 2.27 per cent from its previous close of Rs. 1,470.90. The stock opened at Rs. 1,492.95 and moved between a high of Rs. 1,566.95 and a low of Rs. 1,467.80 during the session. […]

Glenmark Shares Rise After USFDA Clears US Facility | Udaipur Kiran

[ad_1] Mumbai, November 27 (Udaipur Kiran): Shares of Glenmark Pharmaceuticals were trading higher on the BSE after the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the United States Food & Drug Administration (USFDA) for its manufacturing facility in the USA. The stock was trading at Rs. 1,941.90, […]

Lupin Gains After Receiving USFDA EIR for Sambhajinagar Facility | Udaipur Kiran

[ad_1] Mumbai, 13 November (Udaipur Kiran)। Shares of Lupin edged higher on Thursday after the company announced it has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its Chhatrapati Sambhajinagar (Aurangabad) facility. The EIR follows a product-specific Pre-Approval Inspection (PAI) conducted by the USFDA between September 1–5, 2025. […]